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Abstract
Background: Diabetes is one of the leading causes of death and disability in the United States
including Kentucky. Despite advances in medicine, the current management of type 2 diabetes
mellitus (T2DM) remains challenging. Poor self-management coupled with the increasing
complexity of the disease can lead to poor glycemic control.
Purpose: The purpose of this project was to examine current practices related to insulin-using
patients’ treatment adherence and management of T2DM. In addition, providers’ perceptions on
the management of T2DM were also assessed.
Methods: A retrospective chart review and semi-structured interviews were conducted. Patients
(N = 84) with T2DM, over the age of 18, with hemoglobin A1C > 7.5% and on insulin were
included in the review. Providers (N = 5) were recruited for the interviews.
Results: Despite a lack of assessment in patient adherence, glycemic control improved
significantly at visit 2, demonstrated by a mean A1C reduction of 0.52% (p = 0.001). That
change was found to be statistically significant between the group that received medication
adjustments along with written education and those who did not receive any changes to their
treatment plans. However, though not statistically significant, the most improvement in A1C was
found among those who received medication changes along with verbal and written education.
An inconsistency in the delivered education was also noted.
Conclusion: Overall, the gap in care is in the assessment, documentation and education process
at the practice. The findings suggest a great need for improvement in assessment and
documentation of patient adherence, and development of a standardized diabetes education
delivery model. Information from this project will help build a foundation for future quality
initiatives to improve the delivery of diabetes education at primary care practices.
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An Evaluation of Providers’ Interventions and Patients’ Adherence in Diabetes Management

Introduction

Diabetes is one of the leading causes of death and disability in the United States, and it is
especially prevalent in Kentucky (Kentucky Cabinet for Health and Family Services; KCHFS,
2015). From 2000 to 2013, the prevalence of diabetes in Kentucky adults increased from 6.5% to
10.6%, with approximately 95% having type 2 diabetes mellitus (T2DM; KCHFS, 2015). As of
2014, approximately 11% of adults in Louisville had been diagnosed with diabetes (Center for
Health Equity, 2014). Despite advances in medicine, the current management of T2DM remains
challenging. Poor self-management coupled with the increasing complexity of the disease can
lead to poor glycemic control. The purpose of this practice inquiry project (PIP) was to examine
current practices of providers at a primary care clinic related to patients’ adherence and
management of their T2DM. The identification of a potential gap and barriers to diabetes
management can lead to the development of evidence-based strategies to help providers and
patients effectively manage T2DM.
Background

Diabetes, especially when uncontrolled, is associated with a number of complications such
as retinopathy, nephropathy, neuropathy, and cardiovascular diseases. Diabetes is the leading
cause of adult blindness, end-stage kidney disease, and non-traumatic lower-extremity amputation
(KCHFS, 2015). Individuals with diabetes have a two to four-fold increased risk of developing
coronary artery disease and stroke compared to non-diabetics (KCHFS, 2015). In a prospective
cohort study, glycated hemoglobin (A1C) was found to be associated with mortality in patients
who had poor glycemic control (Landman et al., 2010). The authors also found that
2

PROVIDERS' INTERVENTIONS AND PATIENTS' ADHERENCE
cardiovascular mortality risk in patients with an average A1C of equal or greater than 9% was
three times higher than in patients with A1C of 6.5 to 7%.

Diabetes not only increases the morbidity and mortality and compromises the quality of
life of individuals affected by the disease, it also places a financial burden to the U.S. economy.
The estimated total diabetes cost in the United States in 2012 was $245 billion and in Kentucky in
2013, the cost was $3.85 billion (National Center for Chronic Disease Prevention and Health
Promotion, 2014). Further, there is a positive correlation between diabetes complications,
healthcare cost, and A1C (McBrien et al., 2012).

There are many factors that affect diabetes management. Providers must recognize that the
management of diabetes is very complex for most patients. A systematic review by Nam et al.
(2011) found that a number of variables influence diabetes self-care behaviors consisting of
physical, psychological and social factors. These factors include comorbidities, health beliefs,
knowledge, health literacy, culture, financial resources, and social support (Nam et al., 2011).

Literature Review

Management of chronic disease and prevention of its complications is one of the main
focuses of primary health care. T2DM is a chronic illness that requires continuous medical and
self-care. In order to prevent complications and reduce morbidity and mortality, education on both
the disease process and self-management is crucial. The ultimate goal of diabetes management is
optimal glucose control that leads to reduction of cardiovascular risk and organ damage.
Adherence to medication, self-monitoring of blood glucose (SMBG), diet and lifestyle change are
associated with lower A1C (Schectman, Schorling, & Voss, 2008). Furthermore, every percentage
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drop in A1C can reduce the risk of nephropathy, retinopathy, and neuropathy by 40% (KCHFS,
2015).

Primary care providers must deliver medical interventions and provide education to
include physical activity and diet control. Interventions are best delivered when tailored to
individual patients’ needs. Studies have demonstrated that diabetes education, such as lifestyle
counseling, leads to reduction in A1C, diabetic complications, acute healthcare utilization, and
total cost of health care (Martin & Lipman, 2013; Morrison, Shubina, & Turchin, 2012). In a
systematic review, a significant association was noted between engagement in self-management
education and decrease in A1C (- 0.80) (Chrvala, Sherr, & Lipman, 2015).

Self-Management

Successful diabetes care requires not only the individualization of interventions but also
treatment goals and glycemic targets. The American Diabetes Association (ADA) (2016)
guideline recommends an A1C of less than 7% for most non-pregnant adults. However, more
stringent A1C goals of less than 6.5% could be selected for certain patients, such as individuals
that have no significant cardiovascular disease, have shorter duration of diabetes or lower risks for
hypoglycemia (ADA, 2016).

Personalized A1C goals of less than 8% may be appropriate for patients with a history of
severe hypoglycemia, limited life expectancy, advanced vascular complications, and extensive
comorbid conditions (ADA, 2016). In these patients, particularly older adults and adults at high
risk for cardiovascular disease, more stringent A1C goals could lead to harmful adverse effects.
An observational study based on four large randomized controlled trials found that for a majority
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of adults over 65 years of age, the harms associated with A1C target lower than 7.5% or higher
than 9% outweighed the benefits (Lipska, Krumholz, Soones, & Lee, 2016).

Gerstein et al. (2008) conducted a long-term randomized study with more than 10,000
T2DM patients who were at high risk for cardiovascular disease. Increased mortality rates were
found in the intervention group with A1C goals of less than 6% as compared to the group with
A1C goals of 7 – 7.9%. Based on these results and recommendations from the ADA, providers
should individualize treatment and glycemic goals according to each patient’s needs and
characteristics. Strategies for improving persistent poorly-controlled diabetes mellitus includes:
being cognizant of patients’ lifestyles, medication regimens and comorbid conditions, and
addressing barriers to self-management (Crowley et al., 2014).

Recognition and proper management of co-existing physical and psychological conditions
are beneficial in improving diabetes management. Patients with multiple comorbidities have been
found to frequently experience barriers to self-management due to competing health and financial
demands (Jerant, Friederichs-Fitzwater, & Moore, 2005). Results of a cross-sectional study
showed a significant association between multiple comorbidities and lower perceived health
status and lower levels of physical functioning in older adults (Bayliss, Ellis, & Steiner, 2007).

Psychological conditions such as depression and other emotional stresses are potential
barriers to optimal glycemic control. This is due to the fact that mental health can affect patients’
perceptions about the disease and their self-management behaviors. Depression is also associated
with increased morbidity, mortality, functional limitation, and increased health care costs (Chao,
Nau, Aikens, & Taylor, 2005). In a systematic review and meta-analysis, depression was found to
be associated with a 1.5-fold increased risk of mortality in people with diabetes (Van Dooren et
5
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al., 2013). Lack of awareness from providers regarding patients’ psychological health also affects
diabetes management. Yet, Peyrot et al. (2005) reported that providers expressed a lack of
confidence in their ability to identify and treat psychological problems in patients with diabetes.

Other factors have been associated with successful self-management. For example, the
financial strain placed upon individuals and their families cannot be understated. In a
retrospective cohort design, general financial and medication-specific financial strain was found
to be significantly associated with medication non-adherence, even after income adjustment
(Lyles et al., 2016). In addition, family and social support are closely associated with self-care.
Mayberry and Osborn (2012) found that patients with non-supportive family members reported
lower adherence to their medication regimens and had poorer glycemic control. This finding
suggests that social support should be a valuable factor for providers to assess in addition to
financial strain.

Medical Management
Proper management of diabetes should include the evaluation of each patient’s physical,
psychological, and social factors as mentioned above. In addition, a study by Schectman et al.
(2008) found that adherence to appointments was a strong predictor of glycemic control and that
missed appointments should be assessed as a barrier to diabetes self-management. These potential
barriers should be identified and minimized.

Understanding the clinical interventions and barriers of diabetes management from a
provider’s point of view can lead to quality improvement initiatives. Diabetes management is not
only influenced by patients’ self-care behaviors but also providers’ interventions, such as

6

PROVIDERS' INTERVENTIONS AND PATIENTS' ADHERENCE
pharmacotherapy and education. Providers’ attitudes, perceptions, beliefs, and knowledge about
diabetes management can have an impact on their strategies. Results of the Diabetes, Attitudes,
Wishes, and Needs study revealed that a provider’s prescription practice was associated with his
or her perception of patients’ behaviors (Peyrot et al., 2005). These providers reported that they
were likely to delay the initiation of insulin therapy if they perceived their patients to be less
adherent to medication or appointment regimens (Peyrot et al., 2005).

There are substantial data to support the importance of assessing adherence, comorbidities,
management strategies, potential barriers, and providers’ perceptions in patients with diabetes. A
systematic approach with interventions that focus on healthy lifestyle change, self-management,
prevention of complications, and education can lead to optimal management of diabetes mellitus
(ADA, 2016). However, due to the intricacy of the disease, achievement of optimal diabetes selfmanagement and glycemic control often remains an arduous task. Therefore, the process of
continuous quality improvement can identify treatment gaps and potential barriers and guide
providers to improve the quality of diabetes healthcare services.

Purposes

This practice inquiry project (PIP) was conducted at an outpatient primary care practice
located in south of Kentucky. The clinic provides services such as disease prevention, health
maintenance, diagnosis and treatment of acute illnesses, and management of chronic conditions.
The clinic also serves as the community’s access to most health care services. This primary care
practice includes four physicians, three nurse practitioners, and one nurse navigator. This practice
has a large population of diabetics and there has been no evaluation of the process and outcomes
of their current diabetes management.
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The two main purposes of this project were to: 1) evaluate current management practices
of patients with T2DM who currently have an A1C of greater than 7.5 and are on insulin therapy,
and 2) identify treatment gaps between current practice and target goals with input from the
clinical providers. The specific objectives were to:

1. Assess patients’ comorbidities and medication regimen.
2. Assess documented patients’ adherence to recommended treatment.
3. Describe diabetes-related interventions implemented by providers.
4. Assess changes in A1C between two subsequent visits.
5. Assess any potential barriers to treatment and self-management documented in
providers’ notes.
6. Assess for any missed appointments related to diabetes visits and referrals.
7. Assess providers’ perceptions toward T2DM protocols/guidelines, perceived barriers,
and utilization of diabetes self-management programs.

Methods

Study Design

This gap analysis involved a retrospective chart review of patients with T2DM with an
A1C greater than 7.5% who were on insulin therapy. Data collected on patient demographics
included: gender, age, ethnicity, medical coverage, marital status, body mass index (BMI), and
smoking status. Patients’ comorbidities were evaluated. In Appendix A, the survey instrument
with a complete list of the variables is provided. For examples, conditions such as hypertension,
8
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hyperlipidemia, and depression were assessed. The medication regimen was also evaluated to
include other diabetes medications in addition to insulin.

Patients’ adherence was evaluated based on a diabetes follow-up visit template that was
built into EPIC which is an electronic medical records (EMR) system. The template includes
assessment of each patient’s subjective evaluation of their self-care management. Variables such
as overall adherence to medical plan along with SMBG, current diet, meal planning, and exercise
were reviewed.

Types of diabetes-related interventions along with referrals to a Diabetes SelfManagement Education (DSME) program, dietician, or nurse navigator were evaluated at visit 1.
Interventions such as verbal education, medication adjustments and diabetes written materials
(handouts) were targeted. Verbal education is delivered by providers, licensed practical nurses
(LPN), or medical assistants (MA). Patients can also receive education through mailed letters or
the MyChart service within the EMR. The MyChart program is available to all patients; it gives
them immediate access to their charts and allows for communication with providers through
emails. Changes in A1C between visit 1 and visit 2 were evaluated and how the interventions and
delivery methods impact that change. Data regarding potential barriers and missed appointments
documented in providers’ notes were included in the analysis.
In order to evaluate providers’ perspectives regarding optimal management of T2DM,
focused interviews were conducted. Five primary care providers practicing at the target facility
(two nurse practitioners and three physicians) were asked to respond to questions about the
management in patients’ adherence to recommended treatment guidelines. In Appendix B is an
outline of the questions.
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Informed Consent Process

This PIP was a retrospective chart review along with a targeted interview with providers.
Protection of human subjects was obtained from the University of Kentucky’s Institutional
Review Board (IRB). The Healthcare Office of Research Administration associated with the
practice also approved the project proposal (see Appendix C for copy of IRB approval letter).
Providers were consented prior to the interviews (see Appendix D for a sample of consent form).

Subject Recruitment

The inclusion criteria included: 1) all primary care patients at the clinic; 2) had two
diabetes follow-up visits within the year of 2015 with an ICD-9 or ICD-10 diagnosis code for
T2DM or uncontrolled T2DM; 3) over the age of 18 and not pregnant; 4) had an A1C of greater
than 7.5% and on insulin therapy; and 6) currently not being managed by an endocrinologist.
Charts of patients not meeting these criteria were excluded from the study. After evaluating the
EMRs of 140 patients, only 84 met the specified inclusion criteria.

Providers were contacted and invited to participate in a face-to-face semi-structured
interview that would last approximately 15 minutes. The purpose of the interview was explained
to each provider. Participation was strictly voluntary. Interested providers were provided with
informed consents explaining what the project was about and what they would be expected to do
if they agree to participate. All results were recorded in writing and transferred to an electronic
Microsoft Word document.
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Study Procedures

Medical records were accessed through EPIC which is an electronic, secure, encrypted,
firewall protected EMR. Using the data collection form in Appendix A, chart audits were
conducted in a workroom at the Nursing Institute at a medical building. Data were de-identified
by assigning each patient a unique patient identifier number. A separate worksheet was used to
link the patient EMRs to the correlating unique patient identifier numbers. This worksheet was
stored separately from the data in an authenticated secure, firewall protected folder. The
worksheet was permanently deleted upon conclusion of the data analysis.
The providers’ interviews were confidential and did not contain any identifying
information. Providers’ names and years of experience were not recorded; their roles (e.g.,
APRNs, MDs) were not linked to patient outcome data. Privacy of the individual interview was
ensured thusly: Each interview was conducted in a private room at the office, and only the
provider and the interviewer were present during the interview. Providers’ data were collected on
handwritten papers during the interview and transcribed into electronic Word documents. All
paper records were destroyed after the information was transferred into electronic documents.

All data collected were stored on a password protected, identity authenticated secure,
firewall protected research folder. The information services representatives did not access the
folder; no technical issues were encountered during the study. All data were permanently deleted
upon conclusion of the data analysis.
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Data Analysis

Collected data were recorded into an SPSS spreadsheet. The SPSS software version 22
was used for statistical analysis. The University of Kentucky College of Nursing statistics
department was utilized to help analyze data obtained from the study. Descriptive statistics
including frequency distribution were utilized to assess the patients’ demographic variables,
patients’ adherence and providers’ interventions. The duration of time between two visits was
also evaluated using descriptive statistic.

The paired t-test was utilized to compare changes in glycemic control between the first
and second visit. Means (M) and standard deviations (SD) were used to describe changes in A1C
between the initial and follow-up visit. Spearman correlation coefficient was utilized to assess the
relationship between the number of comorbidities and A1C. One-way analysis of variance
(ANOVA) with post-hoc analysis was utilized to analyze the impact of interventions and delivery
methods on A1C changes. A p-value of less than 0.05 was used to determine significance for all
the statistical tests.
Results
Sample Characteristics
Patients’ demographic data including gender, race, medical coverage, marital status,
smoking status and medication regimen are reported in Table 1. The entire sample (N = 84) was
Caucasian, male (58%), married (60%), non-smoker (88%), with a mean age of 64 years (range
28 - 83) and had Medicare coverage (68%). All patients were insulin-treated T2DM with a
majority of them being on dual or triple therapy.
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Comorbidities
Physical comorbidities in this sample are represented in Figure 1. The most prevalent
comorbidities were hyperlipidemia (87%), hypertension (86%), and obesity (73%). Among the
psychological comorbidities, anxiety (27%) and depression (23%) were the most common.
Overall, the average number of comorbidities among all patients was five, with a range of one to
eleven. There was a weak, positive relationship between the number of comorbidities and A1C
(r = 0.23, p = 0.04).
Adherence
Between the two visits, the two areas most likely to be assessed were SMBG (31% and
32%) and current diet (32% for each visit). Within those completing SMBG (81% and 74%), the
majority were testing one to two times per day. For those having a diet evaluation, most reported
following a low salt diet (Table 2). For the 15% of patients that were assessed for meal planning
at visit 1 and 14% at visit 2, the majority of them did not participate in meal planning. Physical
activity was rarely engaged upon by those who were evaluated for this variable. When looking at
the same patients that were assessed for the same criteria at both visits, it appears that SMBG
(21%) and diet (30%) were the most likely to be discussed.
Glycemic Control
The paired t-test was utilized to compare changes in glycemic control between visit 1 and
visit 2. There was a statistically significant decrease in the A1C from the first visit (M = 9.15, SD
= 1.26) to the second visit (M = 8.63, SD = 1.39; p = 0.001). The mean decrease in A1C was
0.52 with a 95% confidence interval ranging from 0.23 to 0.81.
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Intervention
Interventions that were implemented for visit 1 were evaluated. These included:
medication adjustments, referrals, and education. The types of education encompassed verbal
instruction and written information. The verbal instruction was either given at the point of care
by the provider or after the visit, delivered through the ancillary office staff (LPN/MA). After
evaluating the data, the decision was made to differentiate the education into the generic scripted
handout and those that received individualized verbal instruction. This latter group encompassed
those that received verbal education at the office visit, those who were mailed results with a
personalized message and those who received a message via email (MyChart).
Interventions were found to vary across the sample (see Figure 2). A majority of patients
(61%) received the scripted outline of general diabetes self-management (SMBG, diet, physical
activity, medication adherence, foot and eye care). Based the chart review, 27% of the sample
received the written handout and medication adjustments. Approximately 17% received verbal
and written instructions regarding their A1C and 8% received medication adjustments along with
verbal and written education. There were five patients who were only told no changes would be
made to their medical management.
ANOVA was conducted to explore the impact of interventions on A1C changes from
visit 1 to visit 2. Among the eight groups, there was a statistically significant difference in A1C
changes between the two groups (F = 2.36, p = 0.31). Post-hoc comparisons using the Tukey
HSD test found that the mean difference in A1C for the group that were told to continue
treatment (M = + 1.06, SD = 1.54) was significantly different from those that received
medication adjustments along with diabetes handout (M = - 0.91, SD = 1.36; p = 0.04). No
significant difference between the other groups was found. Though not reaching statistical
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significance, the group that received a combination of medication adjustment, verbal and written
instructions was found to have the highest improvement in A1C (M = - 1.17; p = 0.40) (Figure
3).
Delivery mode. Intervention delivery methods were also assessed. Only 18% of the
sample patients had A1C results at the time of their first visit for providers to address face-toface. The majority of patients (n = 69, 82%) did not have their A1C results at the first visit.
Rather the lab test was drawn at the conclusion with results communicated afterward along with
treatment recommendations. The results and treatment recommendations were then
communicated to patients by either an LPN (19%) or MA (46%). Result letters along with
treatment recommendations were mailed to 30% of the patients and 4% received the information
from providers through MyChart. ANOVA was conducted to explore the impact of each method
of communication on A1C changes from visit 1 to visit 2. There was no statistically significant
difference in A1C changes between the groups (p = 1.41).
Barriers
A total of 14% of patients have documented barriers to diabetes treatment. These
included: physical impairment (limited activity due to the use of wheelchair and cane, and back
problem), lack of desire to learn (patient stated that he or she knew what should be done but did
not want to do it, patient was minimally interested in committing to lifestyle changes), memory
impairment (forgetfulness), depression, and family dynamic (caregiver strain). Furthermore,
financial strain was found to be the most prevalent (8%). Documented financial strain included
inability to afford diabetes medications and supplies, ophthalmology and podiatry care, and
healthy food.
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Follow-up Visits
Documentation of any missed appointments was evaluated during the retrospective chart
review. A majority of patients did not have documentation of missed appointments, only 5% did
not show up to their appointments as scheduled. The average duration between the two visits was
130 days.
Providers’ Interviews
Three physicians and two nurse practitioners participated in the interview. This represents
70% of all full-time primary care providers working at the clinic. The findings of the interview
were grouped into four main themes including guideline, education, barriers, and
recommendations.
Guideline. More than half of the providers (60%) reported utilizing the ADA guideline
when providing care for patients with T2DM. The usual A1C goal for all patients was less than
7%. However, a less stringent A1C goal of less than 8% was reported to be appropriate for some
patients that have an extensive history of cardiac disease.
Education. All providers refer patients that were newly diagnosed or not meeting A1C
goals to their nurse navigator for self-management and nutritional counseling. Dietician referrals
were reported by 40% of the providers but mostly for newly diagnosed patients. One provider
reported that he refers less than 10% of his patients for diabetic counseling due to patients not
wanting to go. All providers utilize diabetes handouts to provide patients with information such
as medications and lifestyle modifications. Most providers (80%) felt that the printed education
materials would be helpful if the patients took time to read them. The reading materials should
facilitate patients to ask important questions related to their diabetes care at follow-up visits. The
providers did not know if patients were utilizing what was being given to them.
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Barriers. Some perceived barriers that prevent patients from adhering to their treatment
plans were mentioned by the providers. These barriers included: financial strain such as inability
to afford healthy foods and medications, lack of insurance coverage, co-existing mental health
issues, lack of understanding of disease course, lack of desire to learn, lack of self-motivation
(e.g., some patients did not want to follow-up every three months and some patients even
requested to be seen every year), and health literacy. In addition, access to a certified diabetes
educator (CDE) was limited. Currently, appointments to meet with a CDE were booked out a full
year in advance.
Recommendations. Some recommendations were suggested by the providers for
improving the current practice of diabetes management. These recommendations included:
individualized diabetic education across visits, education on best practices and nutrition
counseling, utilization of the nurse navigator for newly diagnosed patients, and having a focus on
physical activity and weight control.
Discussion
This PIP, using both quantitative and qualitative methods, aimed to examine the current
management of patients with T2DM. Also treatment gaps to achieve optimal glycemic control
were evaluated. In this practice, among a group of insulin-using T2DM patients who were not at
glycemic goal, there was a reduction in the mean A1C between two visits. A number of issues
were noted in the documented records that offer strategies for improvement.
The results revealed a significant decrease in A1C from visit 1 (M = 9.15%) to visit 2 (M
= 8.63%). As reported by the providers, the usual A1C goal for most patients is less than 7%.
However, for some patients with an extensive history of cardiac disease or multiple comorbid
conditions, a goal of less than 8% was selected by some providers. The individualization of

17

PROVIDERS' INTERVENTIONS AND PATIENTS' ADHERENCE
glycemic targets by providers is consistent with recommendations from the ADA (2016) and
several other research findings (Gerstein et al., 2008; Lipska et al., 2016).
Even though there was a significant improvement in A1C among the sample, 8.6% is still
above the target goal of 7 – 8%. Perhaps this could be due to the comorbidity burden among the
patients included in the project. Several studies have identified the negative effects of co-existing
chronic conditions on diabetes self-management (Bayliss et al., 2007; Jerant et al., 2005),
including frequent barriers to self-care, and lower perceived health status and physical
functioning. The average comorbidities per patient were five and more than 70% of patients had
hyperlipidemia, hypertension, and obesity. In this sample, high number of comorbidities was
found to associate with higher A1C (p = 0.04).
In addition to the physical comorbidity burden found among the study sample, 23% of
patients had depression and 27% of patients had anxiety. This result is consistent with a previous
study by Bot, Pouwer, Zuidersma, Van Melle, and De Jonge (2012), which found that the
prevalence of depression among patients with diabetes is more than three times higher than the
general population, 20 - 25% in comparison to 6.7%. Furthermore, depression can lead to poor
glycemic control and worsened health status (Holt et al., 2014). However, these findings are
limited in their importance as the current treatment of these conditions was not evaluated.
According to the ADA (2016), assessment of patients’ adherence should be a priority in
diabetes management. Assessment of the patient’s adherence to treatment, SMBG, diet, and
physical activity is essential at each diabetes visit. The continuous evaluation of patients’
adherence allows providers to identify the causes of hyperglycemia and to modify treatment
approaches accordingly. However, based on the results of this project, adherence to treatment
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was not consistently assessed or documented by the providers at both visits. Therefore, it was
difficult to evaluate for an overall improvement in self-management behaviors.
Patients’ perceptions of adherence to treatment were evaluated in less than 10% of
patients at both visits. Interestingly, the changes in adherence, though not significant, were found
to correlate with the changes in A1C among these patients. Understanding how patients perceive
their own self-management in total allows for a starting conversation about self-management. It
can be thought of as similar to a pain scale, wherein self-evaluation can be made.
Only a third of the sample (31%) was questioned regarding SMBG, within this group
81% were completing SMBG at visit 1 and 74% at visit 2. It was difficult to evaluate patients’
adherence to SMBG because the recommended regimen was not documented in the charts. The
evaluation of patients’ SMBG at each visit can mitigate the under or overuse of SMBG. This
important self-management tool recommended by the ADA (2016) for all insulin-treated
diabetics was not fully utilized by all patients.
Providers should ensure that patients incorporate glucose values into their selfmanagement plans. Interventions, such as adjusting insulin dosage, food intake, and exercise to
achieve target fasting blood glucose, are the ultimate goal (ADA, 2016). Frequent SMBG can
reduce patients’ risk of hypoglycemia and help them identify factors that cause hyperglycemia
(Elgart, Gonzalez, Prestes, Rucci, & Gagliardino, 2015). In this retrospective chart review, all the
patients were on insulin therapy during the time of evaluation; therefore it is critical that these
patients monitor their glucose on a daily basis.
Diet and exercise were not consistently assessed by providers at each visit. Most who
were asked reported being on a low salt diet with very few engaged in actual meal planning.
Possibly, the high prevalence of co-existing hypertension among the patients accounted for their
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report of limiting salt intake. It may also be that diabetic meal planning is far more complicated
than focusing on eliminating just salt from the diet. Exercise was also rarely asked by the
providers with essentially no one participating in routine exercise.
Physical activity and nutrition are the foundation of T2DM self-management. The ADA
strongly recommends that both are routinely discussed with diabetics. A1C levels have been
shown to decrease not only with routine exercise but also with the level of intensity (Boule,
Haddad, Kenny, Wells, & Sigal, 2001; Boule et al., 2003). Furthermore, the ADA (2016)
recommends either carbohydrate counting for patients on insulin or having a fixed amount of
daily carbohydrates. Each of these lifestyle modifications requires continual reinforcement for
long lasting behavioral change.
Interestingly, the providers in this analysis cited both exercise and diet as being the
cornerstone of diabetes management. Yet this was not reflected in the chart review. Though, a
nutritionist and the DSME program were available for these patients, very few had been referred
for those services. A CDE was also available but those appointments are booked a full year in
advance. The A1C in the sample did decrease most when medication changes were made along
with verbal and written education. Possibly, education was delivered but not charted and
previous referrals were not captured. Unfortunately, patients were not interviewed to assess the
amount of education delivered.
One of the most common perceptions frequently expressed by the providers was that they
did not feel their patients were interested in attending classes or meeting with the dietician. This
may be why so few referrals were made. Even visits with the nurse navigator to provide selfmanagement and nutritional counseling were not utilized. One might surmise that either the
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providers lost faith in their patients’ willingness for self-management or they were discussing
this with the patients who refused the referral.
Chronic disease management is not easy for either providers or patients. Patients have to
make lifestyle changes that are foreign to many of them. Oftentimes, they see the management
within the purview of the providers and the solution is medications. This leads to a strained
relationship between providers and patients. Providers get frustrated, leading to generalizations
about patients, i.e. “nobody will exercise or eat right”, and patients are overwhelmed. Hence, it is
it is easier to eliminate dietary salt than staying away from satisfying carbohydrates.

In this analysis, two-thirds of the sample had a medication adjustment based upon their
A1C. The ADA (2016) emphasizes the importance of a patient-centered pharmacological therapy
along with lifestyle modifications. In this sample, patients who received medication changes
along with some type of education had the most improvement in their A1C. This reemphasizes
the importance of providing education along with medication adjustments. If only medications
were adjusted, the message patients might receive is that medications are more important than
lifestyle changes. Unfortunately, the inconsistent charting made it difficult to draw firm
conclusions.

There was no consistency in the education that was charted in this gap analysis. A
systematic and structured model would ensure that each patient receives the same standard of
quality diabetes education consistent with the ADA guideline. The evaluation of clinic’s resources
and personnel are imperative in designing an effective standardized model of diabetes education.
However, with the lack of access to a CDE, the nurse navigator will probably take on an essential
role. There is evidence that a nurse-driven standardized diabetes education process when
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embedded in a primary care practice significantly improves patient’s A1C (Mendez et al., 2016;
Stellefson, Dipnarine, & Stopka, 2013).
A systematic approach to successful diabetes management requires not only the
implementation of patient-centered interventions but the exploration of barriers to adherence.
Lyles et al., (2016) emphasize the importance of assessing financial factors in achieving
adequate glycemic control. Though only 14% of the sample had documented barriers, financial
strain was the most commonly reported. Due to the sample size (n = 12), correlation with A1C
and reported barriers was not performed. However the average A1C of patients within this group
was higher than the overall average A1C of the entire sample from visit 1 and visit 2 (10.05%
and 9.06% compared to 9.15% and 8.63%, respectively). This might be an area the nurse
navigator could address and assist patients in finding affordable options, i.e., pharmaceutical
patient assistance program.
Effective self-care behaviors entail adherence to treatment, such as medication, diet,
physical activity, and follow-up appointments. A study by Schectman et al., (2008) found that
adherence to appointments was a strong predictor of glycemic control. In this sample, only 5% of
patients missed their scheduled appointments. This sample did comply with recommended
follow-up visits and may indicate the emphasis they placed on attending their scheduled
appointments. What remains in question is their commitment to lifestyle modifications.
Limitations
The design of this PIP as a retrospective chart review from one setting has several
limitations. First, the relatively small sample size of the analysis (N = 84) limits the
generalizability of the findings. Second, the sample from one setting is not a representative of the
general diabetes population at other primary care clinics. There was no diversity in the sample;
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therefore, these findings might not be applicable to other ethnic groups due to different cultural
backgrounds. The results are subject to confounding risk factors that were not measured but
could have an impact on glycemic control, such as hospitalization between visits, steroid therapy,
and acute illness.
This project used existing medical records and providers’ interviews to generate
information for quality improvement initiatives. A paucity of information regarding patients’
adherence was noted in the study results, which could be due to insufficient assessment or
documentation from the providers. However, due to the limited scope of the project, this was not
fully explored.
One limitation of the qualitative data is that it was not obtained from the insights of
patients with T2DM. In-depth interviews with patients would provide an accurate assessment of
their knowledge, self-care behaviors, and barriers to treatment. The triangulation of various
sources of data would provide a more thorough analysis of patients’ adherence and factors that
affect glycemic control.
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Conclusion
Despite the above limitations, the findings from this practice inquiry project contribute to
the literature by emphasizing the importance of continuous diabetes management. Optimal
diabetes management entails comprehensive assessment and evidence-based individualized
interventions. Specifically, a comprehensive assessment that should occur at each follow-up visit
needs to include patient’s self-care behaviors, comorbid conditions, barriers to self-management,
and treatment strategies. This is especially important for the improvement of glycemic control in
patients with persistent poorly-controlled diabetes mellitus.
Overall, the gap in care seems to lie in the assessment, documentation and education
process at the practice. Despite poor assessment of patient adherence, there was a significant
improvement in A1C. This could indicate that there is an issue with documentation among the
providers.
The results of this project have several valuable clinical implications. The findings
suggest a great need for improvement in assessment and documentation of patient adherence, and
development of a standardized diabetes education delivery model. A future project is needed to
explore the utilization and effectiveness of a non-CDE nurse in providing DSME to patients.
Information from this project will help build a foundation for future quality initiatives to improve
the delivery of diabetes education at primary care practices.
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Table 1
Study Demographics

STUDY DEMOGRAPHICS
Variable

Number/Percent

Gender
Males
Females

49 (58.3%)
35 (41.7%)

Race
Caucasian

84 (100%)

Medical Coverage
Private
Passport
Medicare

22 (26.2%)
5 (6%)
57 (67.9%)

Marital Status
Single
Married
Divorced
Widowed
Unknown

8 (9.2%)
50 (59.5%)
10 (11.9%)
14 (16.7%)
2 (2.4%

Smoking status
Smoker
Non-smoker

10 (11.9%)
74 (88.1%)

Medication Regimen
(including insulin)
Mono therapy
Dual therapy
Triple therapy
More than three medications

7 (8.3%)
39 (46.4%)
33 (39.3%)
5 (6%)

TOTAL

84 (100%)
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Table 2
Patient’s Subjective Evaluation of Adherence Assessed at Each Visit

ADHERENCE

PATIENTS (numbers & percentage)
Visit 1

Visit 2

Compliance with treatment
“None of the time”
“Some of the time”
“Most of the time”
“All of the time”

n = 7 (8%)
0 (0%)
2 (28%)
3 (43%)
2 (29%)

n = 11 (13%)
0 (0%)
2 (18%)
1 (9%)
8 (73%)

Glucose monitoring
None
1 – 2 x / week
3 – 4 x / week
1 – 2 x / day
3 – 4 x / day

n = 26 (31%)
5 (19%)
1 (4%)
1 (4%)
14 (54%)
5 (19%)

n = 27 (32%)
7 (26%)
0 (0%)
0 (0%)
14 (52%)
6 (22%)

Current diet
Generally healthy diet
Generally unhealthy diet
Low salt diet

n = 31 (37%)
6 (19%)
5 (16%)
20 (65%)

n = 31 (37%)
3 (10%)
7 (22%)
21 (68%)

Meal planning
None
ADA exchange
No concentrated sweets
Dietician visit

n = 13 (15%)
10 (76%)
1 (8%)
1 (8%)
1 (8%)

n = 12 (14%)
7 (58%)
0 (0%)
3 (25%)
2 (17%)

Physical Activity
None
Rarely
Intermittently

n = 14 (17%)
4 (29%)
9 (64%)
1 (7%)

n = 13 (15%)
3 (23%)
8 (62%)
2 (15%)

TOTAL

N = 84

N = 84
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Comorbidities
N = 84
Hyperlipidemia

73 (87%)

Hypertension

72 (86%)

Obesity

61 (73%)

Neuropathy

39 (46%)

CAD

35 (42%)

Nephropathy

27 (32%)

Anxiety

22 (26%)

Depression

19 (23%)

COPD

19 (23%)

Retinopathy
CVA
Diabetic ulcer
Dementia

17 (20%
8 (10%
8 (10%)
3 (4%)

PVD

2 (2%)

Memory impairment

2 (2%)

Figure 1. Comorbidities .
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Interventions
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Figure 2. Documented Interventions (N = 84).
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Figure 3. A1C changes (Visit 1 – Visit 2).
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Appendix A
Proposed Data Collection Instrument
Patient Identifier: _____ Diagnosis Code: _____ Gender: male/ female/ transgender Age: ___
Race/ethnicity: Caucasian / African-American / Hispanic / Asian / other
Medical coverage: none / private / Passport / Medicaid / Medicare
Marital status: single /married / divorced
Height: _____ Current Weight: ________ Last visit weight: ________ BMI:______
Visit: 1 or 2 (if 2, how many days apart) ____________ Smoking status: smoker/non-smoker
Medication regimen: Oral
 Monotherapy ________
 Dual therapy____________ & ____________
 Triple therapy ___________ & ____________ & ______________
Insulin
 ______________________________________________________
Co-morbidities: retinopathy / neuropathy / foot ulcer / cardiovascular disease (CAD/PVD/CVA)
/ chronic obstructive pulmonary disease (COPD) / nephropathy / obesity / hypertension /
hyperlipidemia
Level of provider: physician / physician assistant / nurse practitioner
Adherence:
Subjective evaluation of compliance with recommended treatment:
All of the time/ most of the time/ some of the time/ none of the time
Glucose monitoring regimen:
5 + x per day/ 3 – 4 x per day/ 1 – 2 x per day/ 3 – 4 x per week/ 1 – 2 x per week
Current diet: diabetic/ generally healthy/ unhealthy/
high fat & cholesterol/ low fat & cholesterol/
high salt/ low salt/ vegetarian
Meal planning: none/ ADA exchange/ no concentrated sweets/ calorie counting/ carb counting/
dietician visit
Exercise: daily/ every other day/ three times a week/ weekly/ intermittent/ none
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Provider’s education:
 diet/physical education __________________________________________________
 acute complications (hypoglycemia/ hyperglycemia/ sick day)____________________
 chronic complications (daily foot exam/ proper footwear/ annual eye exam/ podiatry
visit)__________________________________________________________________
 other diabetes related education (i.e., glucose monitoring)________________________
referral to Diabetes Self-Management Education _______________________________
Potential barriers documented in notes:
 cultural/religious ________________________________________________________
 emotional (e.g., fear of needles) ____________________________________________
 lack of desire to learn ____________________________________________________
 depression _____________________________________________________________
 mental disability ________________________________________________________
 family dynamic _________________________________________________________
 physical impairment (speech/visual/hearing)___________________________________
 financial _______________________________________________________________
A1C level: ________
Was this done prior to visit or after visit:
If this was done prior to visit:
o Provider’s interventions:
 diet/ physical activity education __________________________
 oral medication added or adjusted ________________________
 insulin added or adjusted _______________________________
If this was done after visit:
 Who notified the patient:___________________
 What was done: __________________________
o Provider’s interventions:
 diet/ physical activity education ___________________________
 oral medication added or adjusted _________________________
 insulin added or adjusted ________________________________


When was the patient scheduled for follow-up: ________
o Did the patient follow-up: YES/ NO
 If YES – Go to next visit
 If NO – Missed appointments: no-show/ rescheduled / rescheduled & kept/
cancelled
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Appendix B
Interview questions
1. Do you use to any guideline when providing care for patients with T2DM? If so, which
one do you use?
2. How often do you refer your patients for diabetes self-management education and what
are your thoughts on that?
3. What are some barriers that you have encountered as a provider in helping your patients
who have T2DM reduce their A1C level?
4. What are some perceived potential barriers that prevent your patients from adhering to
their treatment plan? Such as cultural/religious, emotional (e.g., fear of needles), lack of
desire to learn, depression, mental disability, family dynamic, physical impairment
(speech/visual/hearing), financial, health literacy, or other?
5. What educational materials do you provide to your patients that have T2DM? Do you
utilize the printed educational material in the after-visit summary or other?
6. Do you think that providing printed educational materials to patients with T2DM is
helpful in reinforcing the successful management of T2DM? (list 7 core behaviors of
ADA) (healthy eating, being active, monitoring, taking medication, problem
solving, reducing risks and healthy coping.
7. For your patients, what is the usual A1C goal?
8. What are your recommendations for improving current practice of diabetes selfmanagement in patients that are not reaching their A1C goal?
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Appendix C
IRB Letter of Approval
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Appendix D
Sample of Consent Form
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